Compounds > methamphetamine

methamphetamine and Atherosclerotic Parkinsonism

methamphetamine has been researched along with Atherosclerotic Parkinsonism in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (6.25)	18.7374
1990's	12 (37.50)	18.2507
2000's	5 (15.63)	29.6817
2010's	10 (31.25)	24.3611
2020's	3 (9.38)	2.80

Authors

Authors	Studies
Mavri, J; Pregeljc, D; Teodorescu-Perijoc, D; Umek, N; Vianello, R	1
Darke, S; Lappin, JM	1
Bing, G; Dang, DK; Hwang, Y; Jang, CG; Jeong, JH; Kim, HC; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ	1
Arab, A; Drazanova, E; Khairnar, A; Minsterova, A; Rektorova, I; Ruda-Kucerova, J; Starcuk, Z; Szabó, N	1
Lappin, JM; Sara, GE	1
Rusyniak, DE	1
Gupta, SP; Mishra, SK; Singh, MP; Singhal, NK; Tiwari, MN; Yadav, S	1
Carvey, PM; Kousik, SM; Napier, TC	1
Gedzior, JS; Matthew, BJ	1
Doi, D; Murayama, S; Nishimura, K; Onoe, H; Samata, B; Tahara, T; Takahashi, J	1
Fornai, F; Kastsiuchenka, O; Natale, G; Paparelli, A; Pasquali, L; Ruggieri, S	1
Daberkow, DP; Garris, PA; Howard, CD; Keefe, KA	1
Callaghan, RC; Cunningham, JK; Kish, SJ; Sykes, J	1
Carvey, PM; Graves, SM; Kousik, SM; Napier, TC; Zhao, C	1
Brown, VM; Cherry, SR; Khan, AH; Leahy, RM; Nichols, TE; Ossadtchi, A; Smith, DJ	1
Aceves, J; Anaya-Martínez, V; Bannon, MJ; Flores, G; Garcia-Villegas, R; Gonzalez-Barrios, JA; Jiménez, I; Lindahl, M; Martinez-Arguelles, DB; Martinez-Fong, D; Navarro-Quiroga, I; Segovia, J; Trudeau, LE	1
Abbey, R; Alexander, M; Brasic, J; Dannals, RF; Kumar, A; Kuwabara, H; McCann, UD; Palermo, M; Ricaurte, GA; Wong, DF; Ye, W	1
Hashiguchi, H; Ishida, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K	1
Di Monte, DA; Jakowec, MW; Langston, JW; Royland, JE	1
Hashitani, T; Hattori, S; Matsui, N; Nishino, H	1
Corsini, GU; Fornai, F; Maggio, R; Racagni, G; Riva, M; Vaglini, F	1
Hashitani, T; Kumazaki, M; Mizukawa, K; Nishino, H	1
Hatori, K; Kondo, T; Mizuno, Y; Shimada, H; Sugita, Y	1
Dannals, RF; McCann, UD; Ricaurte, GA; Villemagne, V; Wong, DF; Yokoi, F	1
Hashiguchi, H; Ishida, Y; Ishizuka, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K	1
Green, S; Jakowec, MW; Petzinger, GM; Tolwani, RJ; Waggie, K	1
Brown, VM; Cherry, SR; Khan, AH; Lacan, G; Leahy, RM; Melega, WP; Ossadtchi, A; Smith, DJ; Yee, S	1
Johnson, SK; Medina, D; Wagner, GC	1
Matsui, Y; Mogami, H; Moriuchi, S; Shimizu, K; Tamura, K; Yamada, M	1
Dunnett, SB; Morris, BJ; Northrop, AJ; Sirinathsinghji, DJ	1
Hatanaka, H; Ikeda, T; Matsui, Y; Miyao, Y; Mogami, H; Okamoto, Y; Shimizu, K; Tsuda, N; Yamada, M	1
Beresford, IJ; Hall, MD; Heavens, RP; Richards, SJ; Sirinathsinghji, DJ	1

Reviews

6 review(s) available for methamphetamine and Atherosclerotic Parkinsonism

Article	Year
Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review. Experimental neurology, 2021, Volume: 343 Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Methamphetamine; Parkinson Disease, Secondary; Risk Factors; Stroke	2021
Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease. Archives of pharmacal research, 2021, Volume: 44, Issue:7 Topics: Animals; Apoptosis; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Methamphetamine; Mice; Mitochondrial Dynamics; Oxidative Stress; Parkinson Disease, Secondary; Rats	2021
Psychostimulant use and the brain. Addiction (Abingdon, England), 2019, Volume: 114, Issue:11 Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke	2019
Neurologic manifestations of chronic methamphetamine abuse. The Psychiatric clinics of North America, 2013, Volume: 36, Issue:2 Topics: Amphetamine-Related Disorders; Cognition Disorders; Dental Caries; Dyskinesia, Drug-Induced; Humans; Methamphetamine; Paresthesia; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Stereotyped Behavior	2013
Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease? Molecular neurobiology, 2014, Volume: 49, Issue:1 Topics: Animals; Humans; Methamphetamine; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Parkinsonian Disorders; Reactive Nitrogen Species; Rotenone	2014
Experimental models of Parkinson's disease: insights from many models. Laboratory animal science, 1999, Volume: 49, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Reserpine	1999

Other Studies

26 other study(ies) available for methamphetamine and Atherosclerotic Parkinsonism

Article	Year
How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study. Neurotoxicity research, 2020, Volume: 37, Issue:3 Topics: Amphetamine; Animals; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drosophila melanogaster; Humans; Methamphetamine; Models, Neurological; Parkinson Disease, Secondary; Reserpine; Synapses; Vesicular Neurotransmitter Transport Proteins	2020
Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease. Neurotoxicity research, 2019, Volume: 36, Issue:4 Topics: Animals; Behavior, Animal; Brain; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Dopamine Agents; Male; Methamphetamine; Mice, Inbred C57BL; Parkinson Disease, Secondary	2019
Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. The European journal of neuroscience, 2014, Volume: 40, Issue:4 Topics: Animals; Brain; Dopaminergic Neurons; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reward; Risk Factors; Self Administration; Substantia Nigra; Ventral Tegmental Area	2014
Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate. International journal of psychiatry in medicine, 2015, Volume: 50, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Injections, Intramuscular; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Patient Admission; Patient Readmission; Psychotic Disorders; Receptors, Dopamine D2; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substantia Nigra; Treatment Refusal	2015
Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1. Stem cell reports, 2016, Apr-12, Volume: 6, Issue:4 Topics: Aged; Animals; Cell Differentiation; Cells, Cultured; Corpus Striatum; Dopaminergic Neurons; Estradiol; Female; Gene Expression Profiling; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Integrin alpha5beta1; Male; Methamphetamine; Mice, Inbred C57BL; Microscopy, Confocal; Nerve Net; Neural Stem Cells; Oxidopamine; Parkinson Disease, Secondary; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Stem Cell Transplantation; Transplantation, Heterologous	2016
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut. Annals of the New York Academy of Sciences, 2008, Volume: 1139 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catecholamines; Dopamine Agents; Gastrointestinal Tract; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; Parkinson Disease, Secondary; Random Allocation	2008
Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. Journal of neurochemistry, 2011, Volume: 118, Issue:4 Topics: Algorithms; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Electric Stimulation; Electrophysiological Phenomena; Extracellular Space; Kinetics; Male; Methamphetamine; Microelectrodes; Neurons; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Signal Transduction; Sympathectomy, Chemical; Sympatholytics	2011
Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug and alcohol dependence, 2012, Jan-01, Volume: 120, Issue:1-3 Topics: Adult; Amphetamine-Related Disorders; Amphetamines; Appendicitis; Case-Control Studies; Cocaine-Related Disorders; Female; Hospitalization; Humans; Male; Methamphetamine; Middle Aged; Parkinson Disease, Secondary; Propensity Score; Retrospective Studies; Risk Factors	2012
Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport, 2011, Dec-07, Volume: 22, Issue:17 Topics: Amphetamine-Related Disorders; Animals; Biomarkers; Cerebrovascular Disorders; Corpus Striatum; Dopamine; Fluorescein-5-isothiocyanate; Hypoxia, Brain; Male; Methamphetamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley	2011
Statistical analysis of multiplex brain gene expression images. Neurochemical research, 2002, Volume: 27, Issue:10 Topics: Analysis of Variance; Animals; Brain; Dopamine Agents; Gene Expression; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Models, Neurological; Parkinson Disease, Secondary; Reference Values	2002
Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats. Molecular therapy : the journal of the American Society of Gene Therapy, 2006, Volume: 14, Issue:6 Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Humans; Immunohistochemistry; Methamphetamine; Nanoparticles; Neurons; Neurotensin; Oxidopamine; Parkinson Disease, Secondary; Rats; Substantia Nigra; Time Factors; Transfection	2006
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse (New York, N.Y.), 2008, Volume: 62, Issue:2 Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Cocaine; Cognition; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography	2008
Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Brain research, 1996, Jul-15, Volume: 727, Issue:1-2 Topics: Animals; Brain Tissue Transplantation; Caudate Nucleus; Corpus Striatum; Dizocilpine Maleate; Dopamine; Female; Fetal Tissue Transplantation; Levodopa; Mesencephalon; Methamphetamine; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Putamen; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase	1996
Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. Journal of neurochemistry, 1996, Volume: 67, Issue:6 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Dopamine Agents; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Male; Methamphetamine; Mice; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease, Secondary; Tyrosine 3-Monooxygenase	1996
Dynamic regulation of striatal dopaminergic grafts during locomotor activity. Brain research, 1996, Feb-26, Volume: 710, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Transplantation; Corpus Striatum; Dopamine; Extracellular Space; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Stereotyped Behavior; Substantia Nigra; Time Factors	1996
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:10 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Dopamine Uptake Inhibitors; Fibroblast Growth Factor 2; Male; Mesencephalon; Methamphetamine; Mice; Mice, Inbred C57BL; Neostriatum; Neuroprotective Agents; Neurotoxins; Nicotine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tyrosine 3-Monooxygenase	1997
Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts. Neuroscience research, 1998, Volume: 30, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Functional Laterality; Haloperidol; Homovanillic Acid; Kinetics; Levodopa; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Tritium; Tyrosine 3-Monooxygenase	1998
Talipexole protects dopaminergic neurons from methamphetamine toxicity in C57BL/6N mouse. Neuroscience letters, 1998, May-15, Volume: 247, Issue:2-3 Topics: Animals; Azepines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agonists; Enzyme Induction; Free Radical Scavengers; Gentisates; Hydroxybenzoates; Hydroxyl Radical; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Receptors, Dopamine D2; Salicylates; Salicylic Acid; Tyrosine 3-Monooxygenase	1998
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Oct-15, Volume: 18, Issue:20 Topics: Adult; Amphetamine-Related Disorders; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Propiophenones; Tomography, Emission-Computed	1998
Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease. Brain research, 1998, Oct-26, Volume: 809, Issue:1 Topics: Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase	1998
Multiplex three-dimensional brain gene expression mapping in a mouse model of Parkinson's disease. Genome research, 2002, Volume: 12, Issue:6 Topics: Animals; Brain Chemistry; Brain Mapping; Central Nervous System Stimulants; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Multigene Family; Parkinson Disease; Parkinson Disease, Secondary	2002
The effects of deprenyl on methamphetamine-induced dopamine depletions. Journal of neural transmission. General section, 1992, Volume: 89, Issue:1-2 Topics: Animals; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Parkinson Disease, Secondary; Selegiline; Serotonin	1992
Neural transplantation in mouse Parkinson's disease. Stereotactic and functional neurosurgery, 1990, Volume: 54-55 Topics: Animals; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Fetal Tissue Transplantation; Graft Survival; Immune Tolerance; Mesencephalon; Methamphetamine; Mice; Mice, Inbred Strains; Parkinson Disease, Secondary; Receptors, Dopamine; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase	1990
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts. Neuroscience, 1990, Volume: 37, Issue:3 Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Autoradiography; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Female; Fetal Tissue Transplantation; Immunohistochemistry; Injections; Methamphetamine; Neural Pathways; Parkinson Disease, Secondary; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra	1990
[Transplant-induced recovery from 6-OHDA lesions of the nigro-striatal dopamine neurons in mice]. No to shinkei = Brain and nerve, 1988, Volume: 40, Issue:7 Topics: Animals; Disease Models, Animal; Dopamine; Female; Hydroxydopamines; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Parkinson Disease, Secondary; Substantia Nigra; Transplantation, Homologous	1988
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion. Neuroscience, 1988, Volume: 27, Issue:1 Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Female; Functional Laterality; Methamphetamine; Parkinson Disease, Secondary; Posture; Pyridinium Compounds; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra	1988